Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Viibryd (vilazodone) and Celexa (citalopram) are both medications used to treat depression in adults, but they have some key differences. Viibryd is a combination of a selective serotonin reuptake inhibitor (SSRI) and a serotonin (5HT1A) receptor partial agonist, while Celexa is a traditional SSRI. This means Viibryd not only increases serotonin levels but also directly acts on serotonin receptors, whereas Celexa solely increases serotonin levels. However, SSRIs like Celexa are considered a first-choice option for treating depression, while Viibryd is not. Unlike Celexa, Viibryd must be taken with food to be effective. Viibryd is less likely to cause sexual side effects compared to Celexa. Both medications have a low risk of weight gain, and both can cause withdrawal symptoms if stopped suddenly. Additionally, Celexa has a risk of causing a serious heart rhythm problem called QT prolongation, while Viibryd does not.
Citalopram (Celexa) is a first-choice medication for treating depression in adults. This antidepressant belongs to the drug class called selective serotonin reuptake inhibitors (SSRIs). Citalopram (Celexa) is typically taken by mouth once daily. It typically takes a few weeks or longer of consistent treatment to notice an improvement to your mood. Common side effects include nausea and dry mouth. There's a low risk for weight gain, but suddenly stopping the medication can lead to withdrawal symptoms (e.g., upset stomach, trouble sleeping, anxiety).